Oral Cancer (American Cancer Society Atlas of Clinical Oncology)
Description:
This new edition of the definitive Oral Cancer, provides a multidisciplinary approach to oral cancer prevention, diagnosis, treatment, and rehabilitation. The effective combination of both authoritative text and colored atlas has produced a thorough examination into this complex disease. Updates include (1) epidemiology, demographics and trends, (2) maxillofacial prosthetics, newer materials and advances in implants, and (3) managing complications in therapy. Expansions in this Fifth Edition comprise (1) new data on viral etiology, genetics and cell markers of oral cancer, and premalignant lesions, (2) diagnosis, staging, imaging, and nutrition, (3) genomics and molecular progression, (4) control of malignant lesions with newer data on agents, mechanisms, and the effectiveness of chemoprevention, and (5) additional illustrations in the MR imaging and PET scans section.
Best prices to buy, sell, or rent ISBN 9781550092158
Frequently Asked Questions about Oral Cancer (American Cancer Society Atlas of Clinical Oncology)
The price for the book starts from $6.78 on Amazon and is available from 6 sellers at the moment.
At BookScouter, the prices for the book start at $5.66. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the Oral Cancer (American Cancer Society Atlas of Clinical Oncology) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Oral Cancer (American Cancer Society Atlas of Clinical Oncology) book, the best buyback offer comes from and is $ for the book in good condition.
The Oral Cancer (American Cancer Society Atlas of Clinical Oncology) book is in very low demand now as the rank for the book is 9,093,346 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.